Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services
FDA, U.S. Food and Drug Administration
U.S. Food & Drug Administration
 
  • A to Z Index
  • Follow FDA
  • FDA Voice Blog
Search
 
Most Popular Searches
 
  • Home
  • Food
  • Drugs
  • Medical Devices
  • Vaccines, Blood & Biologics
  • Animal & Veterinary
  • Cosmetics
  • Radiation-Emitting Products
  • Tobacco Products
 

Import Alert 40-05

  • Print
  • Share
  • E-mail
  • FDA Home
  • Import Program
  • Import Alerts
  • Imports Alerts by Number
  • Import Alert
-

(Note: This import alert represents the Agency's current guidance to FDA field personnel regarding the manufacturer(s) and/or products(s) at issue. It does not create or confer any rights for or on any person, and does not operate to bind FDA or the public).

Import Alert # 40-05
Published Date: 01/18/2012
Type: DWPE
Import Alert Name:
"Detention Without Physical Examination of Infant Formula Due to Failure to Meet Nutrient and Labeling Requirements"

Reason for Alert:
In June 2004, infant formula manufactured in China was found on the store shelves of an Asian retail store in the Chinatown section of Manhattan New York. On July 9, 2004, FDA warned consumers not to feed their infants infant formula from China because the safety and nutritional adequacy of infant formula from China is unknown.

In September 2005, CFSAN issued the "Unregistered Infant Formula at Ethnic Retail Establishments" field assignment. As a result of this assignment, samples of unregistered infant formulas from India and Israel were collected and based on the analyses, certain nutrients were inadequately declared on the label and there were also significant
labeling violations found on the product labels.

Domestic and foreign manufacturers of infant formula who intend to introduce new infant formula into interstate commerce must first provide CFSAN's Office of Nutritional Products, Labeling and Dietary Supplements (ONPLDS) written notification at least 90 days prior to marketing the formula. The notification must contain the name of such
person, the place of business of such person, and all establishments at which such person intends to manufacture such new infant formula. (Refer to Section 412 of the FD&C Act for other provisions applicable to infant formula).

Districts should not detain infant formula products solely on the basis that the manufacturer has not provided this notification to FDA. The products listed on the Red List for this alert have either been analyzed by FDA and they do not meet the nutrient requirements applicable to infant formula as specified in 21 CFR 107.100 or were found to be misbranded due to labeling violations.

Guidance:
Districts may detain without physical examination the infant formula(s) from the identified manufacturers on the attachment for this import alert.

For questions or issues concerning science, science policy, or analytical methodology, contact the Division of Field Science at 301 796-6600.

Refer to the Infant Formula Compliance Program (7321.006) for guidance on product coverage, sample collection, sample preparation, and sample analysis.

Product Description:
Infant formula

Charge:
"The article is subject to refusal of admission pursuant to Section 801(a)(3)in that the infant formula appears to adulterated in that it does not provide the nutrients required by 21 CFR 107.100 [Adulteration, Section 412(a)(1)]".

OASIS CHARGE CODE: NUTR DEF

and/or

"The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the infant formula appears to be misbranded within the meaning of Section 403 in that the labeling fails to use the proper units to declare the nutrients as specified in 21 CFR 107.10 [Misbranded, Section 403(f)]."

OASIS CHARGE CODE: NUTR UNIT

and/or

"The article is subject to refusal of admission pursuant to Section 801(a)(3)in that the infant formula appears to be misbranded within the meaning of Section 403 in that the label or labeling is false and misleading in any particular [Misbranded, Section 403(a)(1)]."

OASIS CHARGE CODE: FALSE

and/or

"The article is subject to refusal of admission pursuant to Section 801(a)(3)in that the infant formula appears to be misbranded within the meaning of Section 403 in that the label or labeling fails to declare the name and place of business of manufacturer, packer, or distributor
[Misbranded, Section 403(e)(1)]."

OASIS CHARGE CODE: Lacks Firm

and/or

"The article is subject to refusal of admission pursuant to Section 801(a)(3)in that the infant formula appears to be misbranded within the meaning of Section 403 in that the label or labeling fails to declare accurate statement of quantity of contents [Misbranded, Section 403(e)(2)]."

OASIS CHARGE CODE: Lacks N/C

and/or

"The article is subject to refusal of admission pursuant to Section 801(a)(3)in that the infant formula appears to be misbranded within the meaning of Section 403 in that the label does not declare the common or usual name [Misbranded, Section 403(i)(1)]."

OASIS CHARGE CODE: Usual Name

and/or

"The article is subject to refusal of admission pursuant to Section 801(a)(3)in that the infant formula appears to be misbranded within the meaning of Section 403 in that the label or labeling fails to list ingredients by common or usual name [Misbranded, Section 403(i)(2)]."

OASIS CHARGE CODE: List Ingre

and/or

"The article is subject to refusal of admission pursuant to Section 801(a)(3)in that the infant formula appears to be misbranded within the meaning of Section 403 in that the label or labeling fails to declare allergens [Misbranded, Section 403(w)]."

OASIS CHARGE CODE: Allergen


List of firms and their products subject to Detention without Physical Examination (DWPE) under this Import Alert (a.k.a. Red List)



INDIA

Nestle India Ltd.
Date Published : 09/18/2009

M-5, Connaught Circus , New Delhi, INDIA
40 C - - -- Formula Prod (Baby)
Date Published: 09/18/2009



ISRAEL

Materna Industries, Limited Partnership
Date Published : 09/18/2009

Kibbutz Maabarot , Maabarot, IL-NOTA ISRAEL
40 C - - -- Formula Prod (Baby)
Date Published: 09/18/2009

Notes:Materna Infant Formula
40 N - - -- Ready To Feed Formula Products
Date Published: 01/18/2012

40 O - - -- Liquid Concentrate Formula Products
Date Published: 01/18/2012

40 P - - -- Powder Formulal Products
Date Published: 01/18/2012


-
-

Links on this page:

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.


  • Accessibility
  • Contact FDA
  • Careers
  • FDA Basics
  • FOIA
  • No Fear Act
  • Site Map
  • Transparency
  • Website Policies
FDA
U.S. Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
Ph. 1-888-INFO-FDA (1-888-463-6332)
Email FDA
  • USA.gov
  • E-mail
  • RSS
  • Twitter
  • Facebook
  • YouTube
  • Flickr
  • For Government
  • For Press
  • Combination Products
  • Advisory Committees
  • Science & Research
  • Regulatory Information
  • Safety
  • Emergency Preparedness
  • International Programs
  • News & Events
  • Training and Continuing Education
  • Inspections/Compliance
  • State & Local Officials
  • Consumers
  • Industry
  • Health Professionals
U.S. Department of Health & Human Services
 

Links on this page: